US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical

CStone Pharmaceuticals, a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science

TiumBio, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients

Nexus Pharmaceuticals, LLC announced the launch of Tranexamic Acid. This milestone is another step for Nexus in its mission to provide

BioArctic AB announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation

SIFI, a leading international pharmaceutical company specializing in ophthalmology, is pleased to announce a scientific collaboration

Argent BioPharma Ltd. a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments

MAXONA Pharmaceuticals today announced the preliminary results of the Phase 1 clinical program for MAX-001, which is in development as a New Molecular Entity

Oncorena is pleased to announce that the FDA has approved the Company's IND application to initiate the Phase I/II study Oncorella-1: A Phase 1/2